Srikumar Chellappan
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Ubiquitin and proteasome pathways
- Mitochondrial Function and Pathology
- RNA Research and Splicing
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer
- Nuclear Structure and Function
Papers in
-
- Cell death mechanisms and regulation 2
- Metabolism, Diabetes, and Cancer 1
- TGF-β signaling in diseases 1
- Oncology 4
- Cancer-related Molecular Pathways 3
- Co-authors
- S. Rastogi (2 shared papers)Piyali Dasgupta (3 shared papers)Gina Fusaro (1 shared paper)Bharat Joshi (1 shared paper)Sarmistha Banerjee (1 shared paper)George R. Simon (1 shared paper)Courtney Schaal (1 shared paper)John L. Cleveland (1 shared paper)
- Journals
- Journal of Biological Chemistry (2 papers)Cancer Letters (1 paper)Current Molecular Medicine (1 paper)Journal of Ovarian Research (1 paper)PLoS ONE (1 paper)
- Partner nations
- United StatesChinaUnited Arab Emirates
In The Last Decade
Srikumar Chellappan
10 papers receiving 548 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 139
- Molecular Biology 412
- Oncology 129
- Cell Biology 71
- Biochemistry 19
Countries citing papers authored by Srikumar Chellappan
This map shows the geographic impact of Srikumar Chellappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srikumar Chellappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srikumar Chellappan more than expected).
Fields of papers citing papers by Srikumar Chellappan
This network shows the impact of papers produced by Srikumar Chellappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srikumar Chellappan. The network helps show where Srikumar Chellappan may publish in the future.
Co-authors
The 25 scholars most cited alongside Srikumar Chellappan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 288 | |
| 2 | 2007 | 98 | |
| 3 | 2013 | 45 | |
| 4 | E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. | 1998 | 42 |
| 5 | 2016 | 37 | |
| 6 | 2006 | 23 | |
| 7 | 2022 | 13 | |
| 8 | 2006 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2020 | 1 |
About Srikumar Chellappan
Srikumar Chellappan is a scholar working on Molecular Biology, Oncology, Cancer Research, Biotechnology and Psychiatry and Mental health, having authored 10 papers that have together received 556 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Cancer Research and Treatments (2 papers), Cell death mechanisms and regulation (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Metabolism, Diabetes, and Cancer (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Cancer Research (139 citations), Molecular Biology (412 citations), Oncology (129 citations), Cell Biology (71 citations) and Biochemistry (19 citations). Srikumar Chellappan has collaborated with scholars based in United States, China and United Arab Emirates. Frequent co-authors include S. Rastogi, Piyali Dasgupta, Gina Fusaro, Bharat Joshi, Sarmistha Banerjee, George R. Simon, Courtney Schaal, John L. Cleveland, David K. Strom and John Nip. Their work appears in journals such as Journal of Biological Chemistry, Cancer Letters, Current Molecular Medicine, Journal of Ovarian Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.